| Literature DB >> 26923600 |
Jean-Baptiste Renaud1, Charlotte Boix1, Marine Charpentier1, Anne De Cian1, Julien Cochennec1, Evelyne Duvernois-Berthet1, Loïc Perrouault1, Laurent Tesson2, Joanne Edouard3, Reynald Thinard2, Yacine Cherifi4, Séverine Menoret2, Sandra Fontanière4, Noémie de Crozé3, Alexandre Fraichard4, Frédéric Sohm3, Ignacio Anegon2, Jean-Paul Concordet5, Carine Giovannangeli6.
Abstract
Genome editing has now been reported in many systems using TALEN and CRISPR-Cas9 nucleases. Precise mutations can be introduced during homology-directed repair with donor DNA carrying the wanted sequence edit, but efficiency is usually lower than for gene knockout and optimal strategies have not been extensively investigated. Here, we show that using phosphorothioate-modified oligonucleotides strongly enhances genome editing efficiency of single-stranded oligonucleotide donors in cultured cells. In addition, it provides better design flexibility, allowing insertions more than 100 bp long. Despite previous reports of phosphorothioate-modified oligonucleotide toxicity, clones of edited cells are readily isolated and targeted sequence insertions are achieved in rats and mice with very high frequency, allowing for homozygous loxP site insertion at the mouse ROSA locus in particular. Finally, when detected, imprecise knockin events exhibit indels that are asymmetrically positioned, consistent with genome editing taking place by two steps of single-strand annealing.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26923600 DOI: 10.1016/j.celrep.2016.02.018
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423